Gene Symbol | Pearson Correlation Coefficient |
---|---|
SPON1 | 0.912 |
NTRK2 | 0.912 |
SLC1A2 | 0.899 |
GJA1 | 0.893 |
TMEM47 | 0.887 |
GPAM | 0.882 |
SLC39A12 | 0.882 |
METTL7A | 0.881 |
ETNPPL | 0.874 |
SLC4A4 | 0.872 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
FER1L6 | -0.459 |
CD163L1 | -0.45 |
GADL1 | -0.434 |
CD244 | -0.409 |
L1TD1 | -0.408 |
SCARA5 | -0.395 |
SLC47A1 | -0.392 |
FCER2 | -0.387 |
KLHDC7B | -0.386 |
GALR1 | -0.384 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB00231 | Temazepam | Small Molecule | 846-50-4 | Approved|Investigational | Target |
DB00546 | Adinazolam | Small Molecule | 37115-32-5 | Approved | Target |
DB00683 | Midazolam | Small Molecule | 59467-70-8 | Approved|Illicit | Target |
DB00690 | Flurazepam | Small Molecule | 17617-23-1 | Approved|Illicit|Investigational | Target |
DB00801 | Halazepam | Small Molecule | 23092-17-3 | Approved|Illicit|Withdrawn | Target |
DB00829 | Diazepam | Small Molecule | 439-14-5 | Approved|Illicit|Investigational | Target |
DB00842 | Oxazepam | Small Molecule | 604-75-1 | Approved | Target |
DB00897 | Triazolam | Small Molecule | 28911-01-5 | Approved|Investigational | Target |
DB00898 | Ethanol | Small Molecule | 64-17-5 | Approved | Target |
DB01215 | Estazolam | Small Molecule | 29975-16-4 | Approved|Illicit | Target |
DB01558 | Bromazepam | Small Molecule | 1812-30-2 | Approved|Illicit|Investigational | Target |
DB01559 | Clotiazepam | Small Molecule | 33671-46-4 | Approved|Illicit | Target |
DB01567 | Fludiazepam | Small Molecule | 3900-31-0 | Approved|Illicit | Target |
DB01587 | Ketazolam | Small Molecule | 27223-35-4 | Approved | Target |
DB01588 | Prazepam | Small Molecule | 2955-38-6 | Approved|Illicit | Target |
DB01589 | Quazepam | Small Molecule | 36735-22-5 | Approved|Illicit | Target |
DB01594 | Cinolazepam | Small Molecule | 75696-02-5 | Approved | Target |
DB01595 | Nitrazepam | Small Molecule | 146-22-5 | Approved | Target |
DB00186 | Lorazepam | Small Molecule | 846-49-1 | Approved | Target |
DB00189 | Ethchlorvynol | Small Molecule | 113-18-8 | Approved|Illicit|Withdrawn | Target |
DB00228 | Enflurane | Small Molecule | 13838-16-9 | Approved|Investigational | Target |
DB00231 | Temazepam | Small Molecule | 846-50-4 | Approved|Investigational | Target |
DB00237 | Butabarbital | Small Molecule | 125-40-6 | Approved|Illicit | Target |
DB00241 | Butalbital | Small Molecule | 77-26-9 | Approved|Illicit | Target |
DB00273 | Topiramate | Small Molecule | 97240-79-4 | Approved | Target |
DB00292 | Etomidate | Small Molecule | 33125-97-2 | Approved | Target |
DB00306 | Talbutal | Small Molecule | 115-44-6 | Approved|Illicit | Target |
DB00312 | Pentobarbital | Small Molecule | 76-74-4 | Approved|Investigational | Target |
DB00334 | Olanzapine | Small Molecule | 132539-06-1 | Approved|Investigational | Target |
DB00349 | Clobazam | Small Molecule | 22316-47-8 | Approved|Illicit | Target |
DB00371 | Meprobamate | Small Molecule | 57-53-4 | Approved|Illicit | Target |
DB00402 | Eszopiclone | Small Molecule | 138729-47-2 | Approved|Investigational | Target |
DB00404 | Alprazolam | Small Molecule | 28981-97-7 | Approved|Illicit|Investigational | Target |
DB00463 | Metharbital | Small Molecule | 50-11-3 | Withdrawn | Target |
DB00475 | Chlordiazepoxide | Small Molecule | 58-25-3 | Approved|Illicit|Investigational | Target |
DB00543 | Amoxapine | Small Molecule | 14028-44-5 | Approved | Target |
DB00555 | Lamotrigine | Small Molecule | 84057-84-1 | Approved|Investigational | Target |
DB00628 | Clorazepate | Small Molecule | 23887-31-2 | Approved|Illicit | Target |
DB00659 | Acamprosate | Small Molecule | 77337-76-9 | Approved|Investigational | Target |
DB00753 | Isoflurane | Small Molecule | 26675-46-7 | Approved | Target |
DB00794 | Primidone | Small Molecule | 125-33-7 | Approved | Target |
DB00801 | Halazepam | Small Molecule | 23092-17-3 | Approved|Illicit|Withdrawn | Target |
DB00818 | Propofol | Small Molecule | 2078-54-8 | Approved|Investigational | Target |
DB00829 | Diazepam | Small Molecule | 439-14-5 | Approved|Illicit|Investigational | Target |
DB00842 | Oxazepam | Small Molecule | 604-75-1 | Approved | Target |
DB00897 | Triazolam | Small Molecule | 28911-01-5 | Approved|Investigational | Target |
DB01028 | Methoxyflurane | Small Molecule | 76-38-0 | Approved|Investigational | Target |
DB01049 | Ergoloid mesylate | Small Molecule | 8067-24-1 | Approved | Target |
DB01068 | Clonazepam | Small Molecule | 1622-61-3 | Approved|Illicit | Target |
DB01107 | Methyprylon | Small Molecule | 125-64-4 | Approved|Illicit|Withdrawn | Target |
DB01159 | Halothane | Small Molecule | 151-67-7 | Approved | Target |
DB01189 | Desflurane | Small Molecule | 57041-67-5 | Approved | Target |
DB01205 | Flumazenil | Small Molecule | 78755-81-4 | Approved | Target |
DB01215 | Estazolam | Small Molecule | 29975-16-4 | Approved|Illicit | Target |
DB01236 | Sevoflurane | Small Molecule | 28523-86-6 | Approved | Target |
DB01437 | Glutethimide | Small Molecule | 77-21-4 | Approved|Illicit | Target |
DB01588 | Prazepam | Small Molecule | 2955-38-6 | Approved|Illicit | Target |
DB01589 | Quazepam | Small Molecule | 36735-22-5 | Approved|Illicit | Target |
DB01708 | Prasterone | Small Molecule | 53-43-0 | Approved|Investigational|Nutraceutical | Target |
DB01956 | Taurine | Small Molecule | 107-35-7 | Approved|Nutraceutical | Target |
DB09118 | Stiripentol | Small Molecule | 49763-96-4 | Approved | Target |
DB11582 | Thiocolchicoside | Small Molecule | 602-41-5 | Approved|Investigational | Target |
DB11901 | Apalutamide | Small Molecule | 956104-40-8 | Approved|Investigational | Target |
DB00555 | Lamotrigine | Small Molecule | 84057-84-1 | Approved|Investigational | Target |
DB06579 | Adipiplon | Small Molecule | 840486-93-3 | Investigational | Target |
DB13983 | 5,7,2G??-trihydroxy-6,8-dimethoxyflavone | Small Molecule | 159359-22-5 | Experimental | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of GABRG1 gene | 27153756 |
D019386 | Alendronate | Alendronate affects the expression of GABRG1 mRNA | 16079270 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in increased expression of GABRG1 mRNA | 28522335 |
D005680 | gamma-Aminobutyric Acid | gamma-Aminobutyric Acid results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG1 protein] | 29038840 |
D005680 | gamma-Aminobutyric Acid | Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
D005680 | gamma-Aminobutyric Acid | Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
D005680 | gamma-Aminobutyric Acid | tiotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
D005680 | gamma-Aminobutyric Acid | tiotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
D005680 | gamma-Aminobutyric Acid | tiotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of GABRG1 mRNA | 16483693 |
D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GABRG1 mRNA | 18164116 |
D001640 | Bicuculline | Bicuculline results in decreased expression of GABRG1 mRNA | 9600394 |
C006780 | bisphenol A | bisphenol A results in decreased expression of GABRG1 mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased expression of GABRG1 mRNA | 29097150 |
D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GABRG1 mRNA | 22079614 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of GABRG1 mRNA | 12734012 |
D003471 | Cuprizone | Cuprizone results in decreased expression of GABRG1 mRNA | 27523638 |
D004026 | Dieldrin | Dieldrin results in decreased expression of GABRG1 mRNA | 9600394 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GABRG1 mRNA | 18164116 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of GABRG1 mRNA | 16079270 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of GABRG1 mRNA | 29097150 |
D015738 | Famotidine | Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
D015738 | Famotidine | Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
D005419 | Flavonoids | Flavonoids results in increased expression of GABRG1 mRNA | 18035473 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of GABRG1 mRNA | 23811191 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride affects the expression of GABRG1 mRNA | 16079270 |
C023990 | tiotidine | tiotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
C023990 | tiotidine | tiotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
C023990 | tiotidine | tiotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG1 protein]] | 15363660 |
D014241 | Trichloroethylene | Trichloroethylene results in decreased methylation of GABRG1 gene | 27618143 |
D014635 | Valproic Acid | Valproic Acid results in decreased methylation of GABRG1 gene | 29154799 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of GABRG1 gene | 25560391 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004890 | GABA-A receptor activity | CONTRIBUTES_TO | IBA | 21873635 |
GO:0004890 | GABA-A receptor activity | - | IEA | - |
GO:0005230 | extracellular ligand-gated ion channel activity | CONTRIBUTES_TO | IBA | 21873635 |
GO:0005230 | extracellular ligand-gated ion channel activity | - | IEA | - |
GO:0005237 | inhibitory extracellular ligand-gated ion channel activity | - | IBA | 21873635 |
GO:0005254 | chloride channel activity | - | IBA | 21873635 |
GO:0005254 | chloride channel activity | - | IEA | - |
GO:0008503 | benzodiazepine receptor activity | CONTRIBUTES_TO | IBA | 21873635 |
GO:0022851 | GABA-gated chloride ion channel activity | - | IBA | 21873635 |
GO:0050811 | GABA receptor binding | - | IEA | - |
GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0007165 | signal transduction | - | IBA | 21873635 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | - | IBA | 21873635 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | - | IEA | - |
GO:0007268 | chemical synaptic transmission | - | IBA | 21873635 |
GO:0007268 | chemical synaptic transmission | - | IEA | - |
GO:0034220 | ion transmembrane transport | - | IBA | 21873635 |
GO:0042391 | regulation of membrane potential | - | IBA | 21873635 |
GO:0050877 | nervous system process | - | IBA | 21873635 |
GO:0051932 | synaptic transmission, GABAergic | - | IBA | 21873635 |
GO:0060078 | regulation of postsynaptic membrane potential | - | IBA | 21873635 |
GO:1902476 | chloride transmembrane transport | - | IBA | 21873635 |
GO:1902476 | chloride transmembrane transport | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005887 | integral component of plasma membrane | - | IBA | 21873635 |
GO:0030054 | cell junction | - | IEA | - |
GO:0032590 | dendrite membrane | - | IBA | 21873635 |
GO:0034707 | chloride channel complex | - | IEA | - |
GO:0043005 | neuron projection | - | IBA | 21873635 |
GO:0043235 | receptor complex | - | IEA | - |
GO:0045202 | synapse | - | IBA | 21873635 |
GO:0045211 | postsynaptic membrane | - | IEA | - |
GO:0098794 | postsynapse | - | IBA | 21873635 |
GO:1902711 | GABA-A receptor complex | - | IBA | 21873635 |
KEGG ID | KEGG Term |
---|---|
hsa04080 | Neuroactive ligand-receptor interaction |
Reactome ID | Reactome Term | Evidence |
---|
PMID | Title (Year) | Author | Journal |
---|---|---|---|
22384067 | Transcriptome-wide survey of mouse CNS-derived cells reveals monoallelic expression within novel gene families. (2012) | Li SM | PLoS One |
15024690 | Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. (2004 Apr) | Edenberg HJ | Am J Hum Genet |
22662011 | GABA-A receptor genes do not play a role in genetics of Lesch's typology in Caucasian subjects. (2012 May 9) | Grzywacz A | Arch Med Sci |
21919924 | GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. (2012 Apr) | Ittiwut C | Alcohol Clin Exp Res |
1321425 | Human chromosomal localization of genes encoding the gamma 1 and gamma 2 subunits of the gamma-aminobutyric acid receptor indicates that members of this gene family are often clustered in the genome. (1992 Jul 1) | Wilcox AS | Proc Natl Acad Sci U S A |
17507911 | Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene. (2008 Mar) | Covault J | Neuropsychopharmacology |
18818659 | GABRG1 and GABRA2 as independent predictors for alcoholism in two populations. (2009 Apr) | Enoch MA | Neuropsychopharmacology |
22072270 | Genome-wide association study identifies 5q21 and 9p24.1 (KDM4C) loci associated with alcohol withdrawal symptoms. (2012 Apr) | Wang KS | J Neural Transm (Vienna) |
26250693 | GABRA2 Alcohol Dependence Risk Allele is Associated with Reduced Expression of Chromosome 4p12 GABAA Subunit Genes in Human Neural Cultures. (2015 Sep) | Lieberman R | Alcohol Clin Exp Res |
24166645 | A GABRA2 variant is associated with increased stimulation and 'high' following alcohol administration. (2014 Jan-Feb) | Arias AJ | Alcohol Alcohol |
25655461 | Clinically relevant genetic biomarkers from the brain in alcoholism with representation on high resolution chromosome ideograms. (2015 Apr 15) | Manzardo AM | Gene |
26087834 | Adaptation of Subjective Responses to Alcohol is Affected by an Interaction of GABRA2 Genotype and Recent Drinking. (2015 Jul) | Kosobud AE | Alcohol Clin Exp Res |
17976953 | Interpopulation linkage disequilibrium patterns of GABRA2 and GABRG1 genes at the GABA cluster locus on human chromosome 4. (2008 Jan) | Ittiwut C | Genomics |
27355804 | SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways. (2016 Jul) | Perez-Rubio G | Pharmacogenomics |
19426171 | Associations among GABRG1, level of response to alcohol, and drinking behaviors. (2009 Aug) | Ray LA | Alcohol Clin Exp Res |